Nonalcoholic fatty liver disease and the risk of post-endoscopic retrograde cholangiopancreatography pancreatitis: the hidden danger
Authors:
- 18 January 2021
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Gastroenterology
- Vol. 56 (3) , 369-373
Abstract
Nonalcoholic fatty liver disease (NAFLD) has been identified as risk factor for several diseases; however, its association with post endoscopic retrograde cholangiopancreatography pancreatitis (PEP) has not been studied. To assess whether NAFLD is a risk factor for the development of PEP. We performed a retrospective multicenter study. All patients who underwent ERCP during 2013–2016 at either the Shaare Zedek Medical Center in Jerusalem or EMMS Nazareth hospital and who had a diagnosis of NAFLD by abdominal imaging were eligible for inclusion. Four hundred and one patients were included, among them, 38 (9.5%) were diagnosed with PEP according to clinical, laboratory and radiological criteria. In univariate analysis, the following risk factors were associated with increased risk for PEP; Fatty liver (OR 2.363, p = .01), elevated levels of aspartate transaminase (OR 1.008, p = .04), ALT (OR 0.979, p = .0007), alkaline phosphatase (OR 1.008, p = .01), gamma-glutamyl transferase (OR 1.014, p = .0005) and total bilirubin (OR 1.141, p = .005). In multivariate logistic regression analysis, only NAFLD showed statistically significant association with PEP (OR 3.224, 95% CI 1.548-6.713, p = .001) with receiver operator characteristics (ROC) area under the curve (AUC) of 0.8156. NAFLD was shown to be a risk factor for PEP. Therefore, we suggest considering prophylactic pancreatic stenting and/or NSAID’s suppositories among these patients.Keywords
This publication has 22 references indexed in Scilit:
- Utilization trends in inpatient endoscopic retrograde cholangiopancreatography (ERCP): A cross-sectional US experienceEndoscopy International Open, 2017
- Risk factors for post-ERCP pancreatitis: A systematic review and meta-analysisThe Surgeon, 2015
- Endoscopic retrograde pancreatography: When should we do it?World Journal of Gastrointestinal Endoscopy, 2015
- Prophylaxis of post-ERCP pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Guideline – Updated June 2014Endoscopy, 2014
- Risk factors for post-ERCP pancreatitis: a systematic review of clinical trials with a large sample size in the past 10 yearsEuropean Journal of Medical Research, 2014
- Prevention of post-ERCP pancreatitisWorld Journal of Gastrointestinal Pathophysiology, 2014
- Classification of acute pancreatitis—2012: revision of the Atlanta classification and definitions by international consensusGut, 2012
- Role of endoscopic retrograde cholangiopancreatography in acute pancreatitisWorld Journal of Gastroenterology, 2007
- Pancreatic stenting prevents pancreatitis after biliary sphincterotomy in patients with sphincter of Oddi dysfunctionGastroenterology, 1998
- Complications of Endoscopic Biliary SphincterotomyNew England Journal of Medicine, 1996